Arformoterol Tartrate Solution
Product Images NDC 70756-612

12 FDA label images from Lifestar Pharma Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 70756-612). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 01)

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 01)
Chemical structure of arformoterol tartrate, showing the molecular arrangement of the active ingredient as displayed in the image.*
FDA Label Image

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 02)

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 02)
A line graph showing mean change from baseline FEV1 (L) over 12 hours postdose in Clinical Trial A at Week 0 (Day 1). Two lines compare placebo and 15 mcg arformoterol tartrate inhalation solution BID. The arformoterol group shows a higher and sustained increase in FEV1 compared to placebo during the 12-hour period.*
FDA Label Image

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 03)

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 03)
This line graph titled 'Mean Change in FEV1 Over Time for Clinical Trial A at Week 12' shows the mean change from baseline FEV1 (L) on the vertical axis and hours postdose on the horizontal axis. Two data series compare placebo and 15 mcg arformoterol tartrate inhalation solution BID, with the arformoterol group showing a noticeable increase in FEV1 compared to placebo over a 12-hour period.*
FDA Label Image

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 04)

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 04)
An instructional diagram showing hands preparing a respiratory inhalation device, specifically illustrating the step of twisting or opening a cap on the device. The drawing emphasizes hand positioning and motion with arrow indicators to guide usage.*
FDA Label Image

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 05)

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 05)
An instructional illustration showing a hand holding an inhalation device above a labeled reservoir. The diagram likely depicts a step in preparing or using the inhalation solution arformoterol tartrate.*
FDA Label Image

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 06)

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 06)
Illustration showing parts related to respiratory inhalation solution delivery, including a mouthpiece labeled in Figure 3 and a face mask labeled in Figure 4, each depicted connected to an inhalation device.*
FDA Label Image

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 07)

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 07)
An instructional diagram showing a compressor unit labeled "COMPRESSOR" with a connection point for tubing labeled "TUBING". The image depicts a tubing connection to the compressor device.*
FDA Label Image

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 08)

Image (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 08)
An instructional illustration showing a person using a respiratory inhalation device by placing the mouth on the device's mouthpiece, demonstrating proper inhalation technique for the medication arformoterol tartrate solution.*
FDA Label Image

Pouch 1 Unit (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 09)

Pouch 1 Unit (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 09)
Label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL sterile solution, packaged in a 2 mL unit-dose vial. The label includes storage instructions, manufacturer information (Lifestar Pharma LLC), and a caution to keep out of reach of children. It is designated for respiratory inhalation use and marked Rx only.*
FDA Label Image

4's Pouch (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 10)

4's Pouch (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 10)
Arformoterol tartrate 15 mcg/2 mL inhalation solution carton label for respiratory use from Lifestar Pharma LLC. The label specifies contents of four sterile unit-dose vials, instructions to store unused vials in the foil pouch, and includes storage temperature and usage information. The product is Rx only.*
FDA Label Image

30 Carton (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 11)

30 Carton (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 11)
Arformoterol Tartrate Inhalation Solution 15 mcg*/2 mL in a carton designed for respiratory (inhalation) use, labeled for oral inhalation only. The box contains 30 sterile unit-dose vials of 2 mL each. Manufactured by Lifestar Pharma LLC. The label advises refrigeration or storage at room temperature for up to 6 weeks and includes usage and storage instructions.*
FDA Label Image

60 (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 12)

60 (0cf1c98c 4caf 4eff B603 6c4b8dd6e148 12)
Carton packaging label for arformoterol tartrate inhalation solution, 15 mcg/2 mL strength. The product is a respiratory inhalation solution intended for oral inhalation only, supplied as 60 sterile unit dose vials per carton by Lifestar Pharma LLC. The label includes storage instructions and manufacturer details, indicating it is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.